224 results
DEFA14A
AWH
Aspira Women`s Health Inc
9 May 24
Additional proxy soliciting materials
6:39pm
Labor Relations Board, the Occupational Safety and Health Administration, the Department of Justice, the Congress, any Inspector General, or any other
8-K
EX-99.1
AWH
Aspira Women`s Health Inc
28 Mar 24
Aspira Women’s Health Reports Fourth Quarter and Full Year 2023 Financial Results
4:50pm
for Ova1Plus from the California Department of Health Care Services. Aspira will be reimbursed at a rate of $897 for all Ova1Plus tests processed
8-K
EX-10.1
gt7dqq30c9dhxz2ohqnl
21 Mar 24
Departure of Directors or Certain Officers
4:10pm
8-K/A
EX-10.1
1oy1zdcxrsm4azu
26 Jan 24
Entry into a Material Definitive Agreement
5:19pm
424B5
g6dq0pi
26 Jan 24
Prospectus supplement for primary offering
5:12pm
8-K
EX-10.1
ya6tpzun8f os7
25 Jan 24
Entry into a Material Definitive Agreement
5:31pm
8-K
EX-99.1
q0ooxu6rm jy
23 Oct 23
Other Events
4:23pm
8-K/A
EX-99.1
084y7
14 Aug 23
Aspira Women’s Health® Reports Second Quarter 2023 Financial Results
5:27pm
8-K
EX-10.1
w4vyxgcdx
24 Jul 23
Entry into a Material Definitive Agreement
5:05pm
424B5
jxxdt77r
24 Jul 23
Prospectus supplement for primary offering
5:01pm
8-K
r9rbv3a3z7kcdxdg6an
28 Jun 23
Other Events
5:26pm
8-K
6fd xb7wrr
2 Jun 23
Departure of Directors or Certain Officers
7:33am
8-K
EX-10.1
txfk1
16 May 23
Departure of Directors or Certain Officers
4:41pm